
Locke Bio is a digital health platform company founded in 2019 that empowers e-commerce brands to launch integrated telehealth services. Their platform provides a customized patient experience, flexible patient care through a network of licensed doctors, built-in LegitScript compliant pharmacy networks, guaranteed compliance with data storage and expedited LegitScript approval, and analytics for patient acquisition and retention. Locke Bio handles the end-to-end process for setting up a complete telehealth brand, including customizable patient intake forms, prescription management, and subscription purchases. They aim to bridge the gap between e-commerce and pharma, making healthcare more transparent and accessible.

Locke Bio is a digital health platform company founded in 2019 that empowers e-commerce brands to launch integrated telehealth services. Their platform provides a customized patient experience, flexible patient care through a network of licensed doctors, built-in LegitScript compliant pharmacy networks, guaranteed compliance with data storage and expedited LegitScript approval, and analytics for patient acquisition and retention. Locke Bio handles the end-to-end process for setting up a complete telehealth brand, including customizable patient intake forms, prescription management, and subscription purchases. They aim to bridge the gap between e-commerce and pharma, making healthcare more transparent and accessible.
Founded: 2019
Headquarters: Toronto, Ontario
Business: White-label telehealth and e-commerce platform for prescription delivery
Notable product: Locke Bio Pay (compliant payment solution)
Employees (approx.): 19
Bridging e‑commerce and online prescription fulfillment while ensuring regulatory compliance.
2019
Digital health / Telehealth
Public profiles report a Seed round on Mar 17, 2020 and list multiple investors in aggregated data.